HK Stock Market Move | Gold mining stocks regain momentum as falling oil prices ease energy inflation concerns; market eyes tonight's CPI data.
Gold mining stocks regained momentum. As of press time, China Gold International (02099) rose 5.11% to HK$181.1, and Shandong Gold (01787) rose 2.66% to HK$18.91.
Gold mining stocks regained momentum. As of press time, CHINAGOLDINTL (02099) rose 5.11% to HK$181.1; Shandong Gold Mining (01787) rose 2.66% to HK$18.91; Chifeng Jilong Gold Mining (06693) rose 2.26% to HK$33.48; LINGBAO GOLD (03330) rose 1.63% to HK$17.42.
On the news front, falling oil prices eased concerns about energy inflation, and combined with a weaker US dollar, gold climbed back above US$4,100/oz. In addition, the latest data from the People's Bank of China showed that gold reserves at the end of October stood at 78.3 million ounces, up 830,000 ounces month-on-month, marking the 24th consecutive month of gold purchases, with the single-month increase hitting a new high since the PBOC resumed gold buying in November 2024.
It is worth noting that at 9:30 tonight, the US Bureau of Labor Statistics will release October CPI data. CITIC Futures noted that falling oil prices and a weaker dollar have driven a phase of recovery in gold and silver, but labor market resilience and high interest rate constraints remain, and the cooling of short-end inflation expectations is not yet sufficient to confirm a policy shift; the sustainability of gold's rebound depends on whether real interest rates and allocation funds can form a resonance.
Related Articles
Shandong Weigao Blood Purification Products (603014.SH) plans to change its securities abbreviation to "Weigao Biotech"

AI megabet backfires! SoftBank (SFTBY.US) posts massive Q2 loss of $7.1 billion, dragged down by data center project writedowns and weakening tech stock holdings.

Harbin Pharmaceutical Group (600664.SH): Ceftizoxime Sodium for Injection Passes Generic Drug Consistency Evaluation
Shandong Weigao Blood Purification Products (603014.SH) plans to change its securities abbreviation to "Weigao Biotech"
AI megabet backfires! SoftBank (SFTBY.US) posts massive Q2 loss of $7.1 billion, dragged down by data center project writedowns and weakening tech stock holdings.

Harbin Pharmaceutical Group (600664.SH): Ceftizoxime Sodium for Injection Passes Generic Drug Consistency Evaluation






